REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 115 filers reported holding REVOLUTION MEDICINES INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,738 | -43.1% | 243,442 | -45.0% | 0.02% | -40.0% |
| Q2 2023 | $11,835 | +23.5% | 442,442 | 0.0% | 0.02% | +8.7% |
| Q1 2023 | $9,583 | -14.9% | 442,442 | -6.5% | 0.02% | -14.8% |
| Q4 2022 | $11,267 | -99.9% | 473,003 | -0.8% | 0.03% | +8.0% |
| Q3 2022 | $9,404,000 | +10.1% | 476,850 | +8.9% | 0.02% | +19.0% |
| Q2 2022 | $8,538,000 | -23.6% | 438,054 | 0.0% | 0.02% | -8.7% |
| Q1 2022 | $11,175,000 | +1.4% | 438,054 | 0.0% | 0.02% | +4.5% |
| Q4 2021 | $11,026,000 | -8.5% | 438,054 | 0.0% | 0.02% | -15.4% |
| Q3 2021 | $12,051,000 | -13.3% | 438,054 | 0.0% | 0.03% | -13.3% |
| Q2 2021 | $13,904,000 | -30.8% | 438,054 | 0.0% | 0.03% | -37.5% |
| Q1 2021 | $20,098,000 | -7.9% | 438,054 | -20.5% | 0.05% | -15.8% |
| Q4 2020 | $21,824,000 | -7.2% | 551,251 | -18.4% | 0.06% | -17.4% |
| Q3 2020 | $23,505,000 | +10.2% | 675,418 | 0.0% | 0.07% | +3.0% |
| Q2 2020 | $21,323,000 | +44.1% | 675,418 | 0.0% | 0.07% | +11.7% |
| Q1 2020 | $14,798,000 | – | 675,418 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 685,011 | $13,508,000 | 35.31% |
| TRV GP III, LLC | 3,604,130 | $71,073,000 | 31.03% |
| Nextech Invest Ltd. | 4,189,529 | $82,618,000 | 26.68% |
| Column Group LLC | 4,577,840 | $90,275,000 | 19.98% |
| Ponoi Management, LLC | 685,011 | $13,508,000 | 18.44% |
| TRV GP IV, LLC | 1,419,900 | $28,000,000 | 16.36% |
| Boxer Capital, LLC | 3,984,264 | $78,570,000 | 4.42% |
| Casdin Capital, LLC | 2,522,300 | $49,740,000 | 3.27% |
| Cormorant Asset Management, LP | 1,995,066 | $39,343,000 | 2.75% |
| BVF INC/IL | 3,255,588 | $64,200,000 | 2.65% |